By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VBL Therapeutics 

6 Jonathan Netanyahu Street

Or Yehuda    60376  Israel
Phone: 97-236-346450 Fax: 97-236-346449


SEARCH JOBS


Industry
Biotechnology






Company News
ASCO15: VBL Therapeutics (VBLX) Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm) 6/1/2015 8:19:58 AM
ASCO15: VBL Therapeutics (VBLX) To Present Phase I/IIa Data From VB-111 In Recurrent Platinum-Resistant Mullerian Cancer At The 2015 ASCO Annual Meeting 6/1/2015 7:33:02 AM
VBL Therapeutics (VBLX) To Webcast Analyst And Investor Event At ASCO Annual Meeting On June 1, 2015 5/26/2015 7:21:43 AM
VBL Therapeutics (VBLX) To Present Positive Phase I/II Data For VB-111 In Recurrent Platinum-Resistant Mullerian Cancer At ASCO Annual Meeting 5/14/2015 7:28:59 AM
VBL Therapeutics (VBLX) Announces First Quarter 2015 Financial Results 5/12/2015 8:25:48 AM
VBL Therapeutics (VBLX) To Report First Quarter 2015 Financial Results On May 12, 2015 5/5/2015 10:20:55 AM
VBL Therapeutics (VBLX) To Present Company Overview At Upcoming Conferences In May 4/30/2015 11:04:36 AM
VBL Therapeutics (VBLX) Announces Fourth Quarter And Full Year 2014 Financial Results 3/25/2015 7:48:37 AM
VBL Therapeutics (VBLX) Reports Interim Topline Results From Phase 2 Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm) 3/25/2015 7:17:51 AM
VBL Therapeutics (VBLX) To Report Fourth Quarter And Full Year 2014 Financial Results On March 25, 2015 3/20/2015 7:29:41 AM
123456
//-->